Related Experiment Video
Updated: May 2, 2026

12:04
Intra-Operative Behavioral Tasks in Awake Humans Undergoing Deep Brain Stimulation Surgery
Published on: January 6, 2011
13.1K
Towards individualized deep brain stimulation: A stereoelectroencephalography-based workflow for neurostimulation
Jeremy Saal1,2, Kelly Kadlec1,3,4, Anusha B Allawala1,2
1UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Biorxiv : the Preprint Server for Biology
|September 2, 2025
Summary
This study introduces a statistical framework using stereoelectroencephalography (sEEG) to find personalized deep brain stimulation (DBS) targets for neuropsychiatric disorders, improving treatment efficacy.
Area of Science:
- Neuroscience
- Neurology
- Psychiatry
Background:
- Deep brain stimulation (DBS) is a growing treatment for neuropsychiatric conditions.
- Individual symptom presentations and neural correlates necessitate personalized therapeutic approaches.
- Current methods for identifying DBS targets can be challenging due to individual variability.
Purpose of the Study:
- To develop and validate a statistics-driven framework for unbiased stimulation testing.
- To identify personalized therapeutic stimulation sites for chronic DBS implantation using inpatient stereoelectroencephalography (sEEG).
- To enhance the precision and efficacy of DBS targeting for diverse neuropsychiatric disorders.
Main Methods:
- Utilized inpatient stereoelectroencephalography (sEEG) in 14 participants (MDD, chronic pain, OCD).
- Integrated a Stimulation Testing Decision Tree with power analysis and effect size calculations.
- Incorporated sham trials to estimate response variability and ensure statistically rigorous results.
Main Results:
- Effect sizes for stimulation-induced symptom changes ranged from -1.59 to +2.59.
- Sham trial variability strongly correlated with stimulation response variability (r = 0.86, p < 0.001).
- 12-15 sham trials are recommended for robust variability estimation; 10 trials per site are sufficient for effect sizes ≥ 1.1.
Conclusions:
- The presented workflow is adaptable across indications for stimulation site testing.
- The framework overcomes challenges in identifying personalized, unbiased, and clinically efficacious DBS targets.
- Incorporating sham trials, effect size, and tolerability testing optimizes DBS target identification.

